Imported Disease Annotations - OMIMObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ZP2 | Human | Oocyte/Zygote/Embryo Maturation Arrest 6 | | IAGP | | 7240710 | | OMIM | | |
|
Imported Disease Annotations - OMIMObject Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ZP2 | Human | Oocyte/Zygote/Embryo Maturation Arrest 6 | | IAGP | | 7240710 | | OMIM | | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# | Reference Title | Reference Citation |
1. | GOAs Human GO annotations | GOA_HUMAN data from the GO Consortium |
2. | ClinVar Automated Import and Annotation Pipeline | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
3. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
PMID:8385033 | PMID:10493829 | PMID:10570015 | PMID:10864856 | PMID:10924747 | PMID:11739644 | PMID:11751269 | PMID:11784014 | PMID:11804956 | PMID:11854410 | PMID:11940668 | PMID:12477932 |
PMID:12852850 | PMID:14511786 | PMID:15489334 | PMID:15950651 | PMID:16407501 | PMID:17474147 | PMID:18033806 | PMID:20394732 | PMID:21873635 | PMID:22472438 | PMID:22889493 | PMID:23355646 |
PMID:23417405 | PMID:24934154 | PMID:26879157 | PMID:28646452 | PMID:28886344 | PMID:29895852 | PMID:30810869 | PMID:32569527 | PMID:32829425 | PMID:33604805 | PMID:33961781 | PMID:35211729 |
PMID:35366744 | PMID:35595959 | PMID:36931917 | PMID:38490181 |
ZP2 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Zp2 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Zp2 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Zp2 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ZP2 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ZP2 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Zp2 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ZP2 (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ZP2 (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Zp2 (Heterocephalus glaber - naked mole-rat) |
|
.
Variants in ZP2
65 total Variants |
Name | Type | Condition(s) | Position(s) | Clinical significance |
GRCh38/hg38 16p13.11-12.1(chr16:14954894-28306843)x3 | copy number gain | See cases [RCV000051828] | Chr16:14954894..28306843 [GRCh38] Chr16:15048751..28318164 [GRCh37] Chr16:14956252..28225665 [NCBI36] Chr16:16p13.11-12.1 |
pathogenic |
NM_003460.2(ZP2):c.1955T>G (p.Met652Arg) | single nucleotide variant | Malignant melanoma [RCV000071031] | Chr16:21198835 [GRCh38] Chr16:21210156 [GRCh37] Chr16:21117657 [NCBI36] Chr16:16p12.3 |
not provided |
NM_003460.2(ZP2):c.1318G>A (p.Glu440Lys) | single nucleotide variant | Malignant melanoma [RCV000071032] | Chr16:21201993 [GRCh38] Chr16:21213314 [GRCh37] Chr16:21120815 [NCBI36] Chr16:16p12.2 |
not provided |
GRCh38/hg38 16p13.3-11.2(chr16:4644892-29170820)x3 | copy number gain | See cases [RCV000133809] | Chr16:4644892..29170820 [GRCh38] Chr16:4694893..29182141 [GRCh37] Chr16:4634894..29089642 [NCBI36] Chr16:16p13.3-11.2 |
pathogenic |
GRCh38/hg38 16p12.3-12.2(chr16:20408020-21244474)x1 | copy number loss | See cases [RCV000139900] | Chr16:20408020..21244474 [GRCh38] Chr16:20419342..21255795 [GRCh37] Chr16:20326843..21163296 [NCBI36] Chr16:16p12.3-12.2 |
uncertain significance |
GRCh37/hg19 16p13.3-11.2(chr16:102839-28327676)x3 | copy number gain | See cases [RCV000203445] | Chr16:102839..28327676 [GRCh37] Chr16:16p13.3-11.2 |
pathogenic |
GRCh37/hg19 16p12.3-11.2(chr16:19590412-29814175)x3 | copy number gain | Breast ductal adenocarcinoma [RCV000207226] | Chr16:19590412..29814175 [GRCh37] Chr16:16p12.3-11.2 |
uncertain significance |
GRCh37/hg19 16p13.3-11.2(chr16:1279324-31926800)x3 | copy number gain | Breast ductal adenocarcinoma [RCV000207053] | Chr16:1279324..31926800 [GRCh37] Chr16:16p13.3-11.2 |
uncertain significance |
NM_001376232.1(ZP2):c.1090G>A (p.Val364Ile) | single nucleotide variant | not provided [RCV003312335]|not specified [RCV004604933] | Chr16:21203134 [GRCh38] Chr16:21214455 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p12.3-11.2(chr16:19424115-30142220)x3 | copy number gain | See cases [RCV000449403] | Chr16:19424115..30142220 [GRCh37] Chr16:16p12.3-11.2 |
pathogenic |
GRCh37/hg19 16p12.3-12.2(chr16:20258837-21405328)x3 | copy number gain | See cases [RCV000447220] | Chr16:20258837..21405328 [GRCh37] Chr16:16p12.3-12.2 |
uncertain significance |
GRCh37/hg19 16p13.3-q24.3(chr16:69193-90274381)x3 | copy number gain | See cases [RCV000446684] | Chr16:69193..90274381 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.2-q24.3(chr16:9273328-89548493)x3 | copy number gain | See cases [RCV000511622] | Chr16:9273328..89548493 [GRCh37] Chr16:16p13.2-q24.3 |
uncertain significance |
maternal UPD(16p) | complex | Hemimegalencephaly [RCV000494707] | Chr16:1280042..33710558 [GRCh37] Chr16:16p13.3-11.2 |
pathogenic |
GRCh37/hg19 16p13.3-12.2(chr16:85880-22442007)x3 | copy number gain | See cases [RCV000511360] | Chr16:85880..22442007 [GRCh37] Chr16:16p13.3-12.2 |
pathogenic |
NM_001376232.1(ZP2):c.547G>C (p.Gly183Arg) | single nucleotide variant | not specified [RCV004293315] | Chr16:21205566 [GRCh38] Chr16:21216887 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.656A>G (p.His219Arg) | single nucleotide variant | not specified [RCV004291114] | Chr16:21205457 [GRCh38] Chr16:21216778 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062) | copy number gain | See cases [RCV000511296] | Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062)x3 | copy number gain | See cases [RCV000512138] | Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
NM_001376232.1(ZP2):c.1666T>A (p.Phe556Ile) | single nucleotide variant | not specified [RCV004298240] | Chr16:21201397 [GRCh38] Chr16:21212718 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p12.3-11.2(chr16:18238275-30177240)x3 | copy number gain | See cases [RCV000512428] | Chr16:18238275..30177240 [GRCh37] Chr16:16p12.3-11.2 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90163275)x3 | copy number gain | not provided [RCV000738917] | Chr16:88165..90163275 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90274695)x3 | copy number gain | not provided [RCV000738918] | Chr16:88165..90274695 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:61451-90294632)x3 | copy number gain | not provided [RCV000738915] | Chr16:61451..90294632 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
NM_001376232.1(ZP2):c.2011+8C>T | single nucleotide variant | not provided [RCV000879877] | Chr16:21198771 [GRCh38] Chr16:21210092 [GRCh37] Chr16:16p12.3 |
benign |
NM_001376232.1(ZP2):c.495A>C (p.Pro165=) | single nucleotide variant | ZP2-related disorder [RCV003920558]|not provided [RCV000881903] | Chr16:21205764 [GRCh38] Chr16:21217085 [GRCh37] Chr16:16p12.2 |
benign |
NM_001376232.1(ZP2):c.1695-2A>G | single nucleotide variant | Oocyte maturation defect 6 [RCV000758705] | Chr16:21199880 [GRCh38] Chr16:21211201 [GRCh37] Chr16:16p12.3 |
pathogenic |
NM_001376232.1(ZP2):c.1691_1694dup (p.Cys566fs) | duplication | Oocyte maturation defect 6 [RCV000758706] | Chr16:21201368..21201369 [GRCh38] Chr16:21212689..21212690 [GRCh37] Chr16:16p12.2 |
pathogenic |
GRCh37/hg19 16p12.3-12.2(chr16:20860025-21334650)x3 | copy number gain | not provided [RCV000848193] | Chr16:20860025..21334650 [GRCh37] Chr16:16p12.3-12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.1115G>C (p.Cys372Ser) | single nucleotide variant | Oocyte maturation defect 6 [RCV000850116] | Chr16:21202276 [GRCh38] Chr16:21213597 [GRCh37] Chr16:16p12.2 |
pathogenic |
NM_001376232.1(ZP2):c.460A>G (p.Ile154Val) | single nucleotide variant | ZP2-related disorder [RCV003920670]|not provided [RCV000887043] | Chr16:21206861 [GRCh38] Chr16:21218182 [GRCh37] Chr16:16p12.2 |
benign |
NM_001376232.1(ZP2):c.222T>A (p.His74Gln) | single nucleotide variant | not provided [RCV000957390] | Chr16:21210122 [GRCh38] Chr16:21221443 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_001376232.1(ZP2):c.1536C>T (p.Asn512=) | single nucleotide variant | not provided [RCV000957389] | Chr16:21201527 [GRCh38] Chr16:21212848 [GRCh37] Chr16:16p12.2 |
benign|likely benign |
GRCh37/hg19 16p13.3-11.2(chr16:4380767-30445350)x3 | copy number gain | not provided [RCV002472599] | Chr16:4380767..30445350 [GRCh37] Chr16:16p13.3-11.2 |
pathogenic |
GRCh37/hg19 16p13.3-11.2(chr16:5805001-34230001) | copy number gain | Microcephaly [RCV001252948] | Chr16:5805001..34230001 [GRCh37] Chr16:16p13.3-11.2 |
pathogenic |
GRCh37/hg19 16p13.3-11.2(chr16:2959279-30190593)x3 | copy number gain | See cases [RCV001263169] | Chr16:2959279..30190593 [GRCh37] Chr16:16p13.3-11.2 |
pathogenic|likely pathogenic |
NM_001376232.1(ZP2):c.278A>G (p.Asp93Gly) | single nucleotide variant | not provided [RCV001354125] | Chr16:21209683 [GRCh38] Chr16:21221004 [GRCh37] Chr16:16p12.2 |
uncertain significance |
GRCh37/hg19 16p12.3-12.2(chr16:20258837-21405328) | copy number gain | not specified [RCV002052524] | Chr16:20258837..21405328 [GRCh37] Chr16:16p12.3-12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.151+1G>A | single nucleotide variant | Oocyte maturation defect 6 [RCV002467398] | Chr16:21211306 [GRCh38] Chr16:21222627 [GRCh37] Chr16:16p12.2 |
likely pathogenic |
NM_001376232.1(ZP2):c.715A>G (p.Met239Val) | single nucleotide variant | not specified [RCV004193807] | Chr16:21204383 [GRCh38] Chr16:21215704 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.1658C>T (p.Pro553Leu) | single nucleotide variant | not specified [RCV004198875] | Chr16:21201405 [GRCh38] Chr16:21212726 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.1487T>G (p.Ile496Ser) | single nucleotide variant | not specified [RCV004151897] | Chr16:21201723 [GRCh38] Chr16:21213044 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.1141G>A (p.Glu381Lys) | single nucleotide variant | not specified [RCV004084868] | Chr16:21202250 [GRCh38] Chr16:21213571 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.1291G>A (p.Glu431Lys) | single nucleotide variant | not specified [RCV004224282] | Chr16:21202020 [GRCh38] Chr16:21213341 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_001376232.1(ZP2):c.1246C>T (p.Arg416Trp) | single nucleotide variant | not specified [RCV004205729] | Chr16:21202145 [GRCh38] Chr16:21213466 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.2228C>T (p.Ser743Leu) | single nucleotide variant | not specified [RCV004239914] | Chr16:21197490 [GRCh38] Chr16:21208811 [GRCh37] Chr16:16p12.3 |
likely benign |
NM_001376232.1(ZP2):c.580G>A (p.Ala194Thr) | single nucleotide variant | not specified [RCV004247086] | Chr16:21205533 [GRCh38] Chr16:21216854 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.1862A>C (p.Asn621Thr) | single nucleotide variant | not specified [RCV004091867] | Chr16:21199635 [GRCh38] Chr16:21210956 [GRCh37] Chr16:16p12.3 |
uncertain significance |
NM_001376232.1(ZP2):c.1247G>A (p.Arg416Gln) | single nucleotide variant | not specified [RCV004216295] | Chr16:21202144 [GRCh38] Chr16:21213465 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.1306G>A (p.Val436Ile) | single nucleotide variant | not specified [RCV004199963] | Chr16:21202005 [GRCh38] Chr16:21213326 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_001376232.1(ZP2):c.74C>G (p.Ser25Trp) | single nucleotide variant | not provided [RCV003886610]|not specified [RCV004220951] | Chr16:21211384 [GRCh38] Chr16:21222705 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.1814A>C (p.His605Pro) | single nucleotide variant | not specified [RCV004161421] | Chr16:21199759 [GRCh38] Chr16:21211080 [GRCh37] Chr16:16p12.3 |
uncertain significance |
NM_001376232.1(ZP2):c.1123G>A (p.Asp375Asn) | single nucleotide variant | not specified [RCV004101170] | Chr16:21202268 [GRCh38] Chr16:21213589 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.1741G>A (p.Gly581Ser) | single nucleotide variant | not specified [RCV004111753] | Chr16:21199832 [GRCh38] Chr16:21211153 [GRCh37] Chr16:16p12.3 |
uncertain significance |
NM_001376232.1(ZP2):c.5C>T (p.Ala2Val) | single nucleotide variant | not specified [RCV004234711] | Chr16:21211543 [GRCh38] Chr16:21222864 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.2000C>T (p.Ser667Phe) | single nucleotide variant | not specified [RCV004149152] | Chr16:21198790 [GRCh38] Chr16:21210111 [GRCh37] Chr16:16p12.3 |
uncertain significance |
NM_001376232.1(ZP2):c.221A>G (p.His74Arg) | single nucleotide variant | not specified [RCV004173850] | Chr16:21210123 [GRCh38] Chr16:21221444 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.970A>G (p.Lys324Glu) | single nucleotide variant | not specified [RCV004075591] | Chr16:21204032 [GRCh38] Chr16:21215353 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.1816G>A (p.Val606Met) | single nucleotide variant | not specified [RCV004191188] | Chr16:21199757 [GRCh38] Chr16:21211078 [GRCh37] Chr16:16p12.3 |
uncertain significance |
NM_001376232.1(ZP2):c.2102T>C (p.Met701Thr) | single nucleotide variant | not specified [RCV004098426] | Chr16:21197616 [GRCh38] Chr16:21208937 [GRCh37] Chr16:16p12.3 |
uncertain significance |
NM_001376232.1(ZP2):c.1475C>T (p.Pro492Leu) | single nucleotide variant | not specified [RCV004133573] | Chr16:21201735 [GRCh38] Chr16:21213056 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.425A>G (p.Gln142Arg) | single nucleotide variant | not specified [RCV004224612] | Chr16:21206896 [GRCh38] Chr16:21218217 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.272T>A (p.Ile91Asn) | single nucleotide variant | not specified [RCV004261979] | Chr16:21209689 [GRCh38] Chr16:21221010 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.1780G>C (p.Asp594His) | single nucleotide variant | not specified [RCV004270934] | Chr16:21199793 [GRCh38] Chr16:21211114 [GRCh37] Chr16:16p12.3 |
uncertain significance |
NM_001376232.1(ZP2):c.688T>C (p.Tyr230His) | single nucleotide variant | not specified [RCV004275142] | Chr16:21205425 [GRCh38] Chr16:21216746 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.557T>C (p.Ile186Thr) | single nucleotide variant | not specified [RCV004264022] | Chr16:21205556 [GRCh38] Chr16:21216877 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.1140C>T (p.Val380=) | single nucleotide variant | not provided [RCV003222863] | Chr16:21202251 [GRCh38] Chr16:21213572 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_001376232.1(ZP2):c.2077G>A (p.Glu693Lys) | single nucleotide variant | not specified [RCV004279276] | Chr16:21197784 [GRCh38] Chr16:21209105 [GRCh37] Chr16:16p12.3 |
uncertain significance |
NM_001376232.1(ZP2):c.538G>T (p.Val180Phe) | single nucleotide variant | not specified [RCV004279688] | Chr16:21205575 [GRCh38] Chr16:21216896 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.720G>A (p.Val240=) | single nucleotide variant | not provided [RCV003411288] | Chr16:21204378 [GRCh38] Chr16:21215699 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_001376232.1(ZP2):c.1103C>T (p.Thr368Ile) | single nucleotide variant | not specified [RCV004487571] | Chr16:21202288 [GRCh38] Chr16:21213609 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.1999T>G (p.Ser667Ala) | single nucleotide variant | not specified [RCV004487572] | Chr16:21198791 [GRCh38] Chr16:21210112 [GRCh37] Chr16:16p12.3 |
uncertain significance |
NM_001376232.1(ZP2):c.2146G>A (p.Ala716Thr) | single nucleotide variant | not specified [RCV004487574] | Chr16:21197572 [GRCh38] Chr16:21208893 [GRCh37] Chr16:16p12.3 |
likely benign |
NM_001376232.1(ZP2):c.2180T>C (p.Val727Ala) | single nucleotide variant | not specified [RCV004487575] | Chr16:21197538 [GRCh38] Chr16:21208859 [GRCh37] Chr16:16p12.3 |
uncertain significance |
NM_001376232.1(ZP2):c.397A>G (p.Met133Val) | single nucleotide variant | not specified [RCV004487579] | Chr16:21206924 [GRCh38] Chr16:21218245 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.92C>T (p.Ala31Val) | single nucleotide variant | not specified [RCV004487582] | Chr16:21211366 [GRCh38] Chr16:21222687 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.107G>T (p.Gly36Val) | single nucleotide variant | ZP2-related disorder [RCV003982040] | Chr16:21211351 [GRCh38] Chr16:21222672 [GRCh37] Chr16:16p12.2 |
benign |
NM_001376232.1(ZP2):c.22G>A (p.Gly8Ser) | single nucleotide variant | not specified [RCV004487576] | Chr16:21211526 [GRCh38] Chr16:21222847 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.907G>A (p.Gly303Arg) | single nucleotide variant | not specified [RCV004487580] | Chr16:21204095 [GRCh38] Chr16:21215416 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.337G>A (p.Gly113Arg) | single nucleotide variant | not specified [RCV004487577] | Chr16:21206984 [GRCh38] Chr16:21218305 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.-9T>C | single nucleotide variant | ZP2-related disorder [RCV003931525] | Chr16:21211556 [GRCh38] Chr16:21222877 [GRCh37] Chr16:16p12.2 |
benign |
NM_001376232.1(ZP2):c.1099+9C>A | single nucleotide variant | ZP2-related disorder [RCV003929428] | Chr16:21203116 [GRCh38] Chr16:21214437 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_001376232.1(ZP2):c.1815C>T (p.His605=) | single nucleotide variant | ZP2-related disorder [RCV003922207] | Chr16:21199758 [GRCh38] Chr16:21211079 [GRCh37] Chr16:16p12.3 |
likely benign |
NM_001376232.1(ZP2):c.2096-5dup | duplication | ZP2-related disorder [RCV003957278] | Chr16:21197626..21197627 [GRCh38] Chr16:21208947..21208948 [GRCh37] Chr16:16p12.3 |
likely benign |
NM_001376232.1(ZP2):c.152-6C>T | single nucleotide variant | ZP2-related disorder [RCV003914671] | Chr16:21210198 [GRCh38] Chr16:21221519 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_001376232.1(ZP2):c.1100-9G>A | single nucleotide variant | ZP2-related disorder [RCV003926822] | Chr16:21202300 [GRCh38] Chr16:21213621 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_001376232.1(ZP2):c.519C>T (p.Asp173=) | single nucleotide variant | ZP2-related disorder [RCV003967351] | Chr16:21205740 [GRCh38] Chr16:21217061 [GRCh37] Chr16:16p12.2 |
benign |
NM_001376232.1(ZP2):c.747T>C (p.Pro249=) | single nucleotide variant | ZP2-related disorder [RCV003982206] | Chr16:21204351 [GRCh38] Chr16:21215672 [GRCh37] Chr16:16p12.2 |
benign |
NM_001376232.1(ZP2):c.2000C>A (p.Ser667Tyr) | single nucleotide variant | not specified [RCV004487573] | Chr16:21198790 [GRCh38] Chr16:21210111 [GRCh37] Chr16:16p12.3 |
uncertain significance |
NM_001376232.1(ZP2):c.91G>A (p.Ala31Thr) | single nucleotide variant | not specified [RCV004487581] | Chr16:21211367 [GRCh38] Chr16:21222688 [GRCh37] Chr16:16p12.2 |
likely benign |
NM_001376232.1(ZP2):c.1895T>G (p.Val632Gly) | single nucleotide variant | not specified [RCV004603773] | Chr16:21199602 [GRCh38] Chr16:21210923 [GRCh37] Chr16:16p12.3 |
uncertain significance |
NM_001376232.1(ZP2):c.1364G>C (p.Arg455Thr) | single nucleotide variant | not specified [RCV004603776] | Chr16:21201947 [GRCh38] Chr16:21213268 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.1070A>G (p.Glu357Gly) | single nucleotide variant | not specified [RCV004603774] | Chr16:21203154 [GRCh38] Chr16:21214475 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.548G>A (p.Gly183Glu) | single nucleotide variant | not specified [RCV004603777] | Chr16:21205565 [GRCh38] Chr16:21216886 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.1687G>A (p.Val563Met) | single nucleotide variant | not specified [RCV004606929] | Chr16:21201376 [GRCh38] Chr16:21212697 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.20G>A (p.Gly7Glu) | single nucleotide variant | not specified [RCV004603771] | Chr16:21211528 [GRCh38] Chr16:21222849 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.743C>T (p.Ser248Phe) | single nucleotide variant | not specified [RCV004603772] | Chr16:21204355 [GRCh38] Chr16:21215676 [GRCh37] Chr16:16p12.2 |
uncertain significance |
NM_001376232.1(ZP2):c.50A>G (p.Asn17Ser) | single nucleotide variant | not specified [RCV004603775] | Chr16:21211498 [GRCh38] Chr16:21222819 [GRCh37] Chr16:16p12.2 |
uncertain significance |
The detailed report is available here: | Full Report | CSV | TAB | Printer | ||||
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
The following QTLs overlap with this region. | Full Report | CSV | TAB | Printer | Gviewer |
G67892 |
|
||||||||||||||||||||||||||||||||||||||||
RH71391 |
|
adipose tissue
|
alimentary part of gastrointestinal system
|
appendage
|
circulatory system
|
ectoderm
|
endocrine system
|
endoderm
|
entire extraembryonic component
|
exocrine system
|
hemolymphoid system
|
hepatobiliary system
|
integumental system
|
mesenchyme
|
mesoderm
|
musculoskeletal system
|
nervous system
|
renal system
|
reproductive system
|
respiratory system
|
sensory system
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
584 | 1028 | 1063 | 572 | 2726 | 870 | 1312 | 2 | 173 | 743 | 101 | 1333 | 2490 | 2228 | 26 | 1795 | 429 | 1148 | 1039 | 77 |
Ensembl Acc Id: | ENST00000572752 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000573114 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000574002 ⟹ ENSP00000460971 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000574091 ⟹ ENSP00000458991 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Ensembl Acc Id: | ENST00000576162 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NM_001376231 ⟹ NP_001363160 | ||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||
Type: | CODING | ||||||||||||
Position: |
|
||||||||||||
Sequence: |
RefSeq Acc Id: | NM_001376232 ⟹ NP_001363161 | ||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||
Type: | CODING | ||||||||||||
Position: |
|
||||||||||||
Sequence: |
RefSeq Acc Id: | NM_001376233 ⟹ NP_001363162 | ||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||
Type: | CODING | ||||||||||||
Position: |
|
||||||||||||
Sequence: |
RefSeq Acc Id: | NM_003460 ⟹ NP_003451 | ||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NR_164788 | ||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||
Type: | NON-CODING | ||||||||||||
Position: |
|
||||||||||||
Sequence: |
RefSeq Acc Id: | NP_003451 ⟸ NM_003460 |
- Peptide Label: | isoform 1 preproprotein |
- UniProtKB: | Q4VAP0 (UniProtKB/Swiss-Prot), Q4VAN9 (UniProtKB/Swiss-Prot), B2R7J2 (UniProtKB/Swiss-Prot), Q4VAP1 (UniProtKB/Swiss-Prot), Q05996 (UniProtKB/Swiss-Prot) |
- Sequence: |
RefSeq Acc Id: | NP_001363160 ⟸ NM_001376231 |
- Peptide Label: | isoform 2 preproprotein |
RefSeq Acc Id: | NP_001363161 ⟸ NM_001376232 |
- Peptide Label: | isoform 1 preproprotein |
- UniProtKB: | Q4VAP0 (UniProtKB/Swiss-Prot), Q4VAN9 (UniProtKB/Swiss-Prot), Q05996 (UniProtKB/Swiss-Prot), B2R7J2 (UniProtKB/Swiss-Prot), Q4VAP1 (UniProtKB/Swiss-Prot) |
RefSeq Acc Id: | NP_001363162 ⟸ NM_001376233 |
- Peptide Label: | isoform 3 preproprotein |
Ensembl Acc Id: | ENSP00000460971 ⟸ ENST00000574002 |
Ensembl Acc Id: | ENSP00000458991 ⟸ ENST00000574091 |
Name | Modeler | Protein Id | AA Range | Protein Structure |
AF-Q05996-F1-model_v2 | AlphaFold | Q05996 | 1-745 | view protein structure |
RGD ID: | 7231555 | ||||||||
Promoter ID: | EPDNEW_H21523 | ||||||||
Type: | multiple initiation site | ||||||||
Name: | ZP2_1 | ||||||||
Description: | zona pellucida glycoprotein 2 | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Experiment Methods: | Single-end sequencing. | ||||||||
Position: |
|
Database | Acc Id | Source(s) |
AGR Gene | HGNC:13188 | AgrOrtholog |
COSMIC | ZP2 | COSMIC |
Ensembl Genes | ENSG00000103310 | Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot |
ENSG00000284588 | UniProtKB/Swiss-Prot | |
Ensembl Transcript | ENST00000574002 | ENTREZGENE |
ENST00000574002.1 | UniProtKB/Swiss-Prot | |
ENST00000574091 | ENTREZGENE | |
ENST00000574091.6 | UniProtKB/Swiss-Prot | |
ENST00000638300.1 | UniProtKB/Swiss-Prot | |
ENST00000640487.3 | UniProtKB/Swiss-Prot | |
Gene3D-CATH | 2.60.40.4100 | UniProtKB/Swiss-Prot |
Zona pellucida, ZP-N domain | UniProtKB/Swiss-Prot | |
GTEx | ENSG00000103310 | GTEx |
ENSG00000284588 | GTEx | |
HGNC ID | HGNC:13188 | ENTREZGENE |
Human Proteome Map | ZP2 | Human Proteome Map |
InterPro | Zona_Pellucida_Domain_gp | UniProtKB/Swiss-Prot |
ZP-C | UniProtKB/Swiss-Prot | |
ZP_chr | UniProtKB/Swiss-Prot | |
ZP_dom | UniProtKB/Swiss-Prot | |
ZP_dom_CS | UniProtKB/Swiss-Prot | |
KEGG Report | hsa:7783 | UniProtKB/Swiss-Prot |
NCBI Gene | 7783 | ENTREZGENE |
OMIM | 182888 | OMIM |
PANTHER | ZONA PELLUCIDA SPERM-BINDING PROTEIN | UniProtKB/Swiss-Prot |
ZONA PELLUCIDA SPERM-BINDING PROTEIN 2 | UniProtKB/Swiss-Prot | |
Pfam | Zona_pellucida | UniProtKB/Swiss-Prot |
PharmGKB | PA37756 | PharmGKB |
PRINTS | ZPELLUCIDA | UniProtKB/Swiss-Prot |
PROSITE | ZP_1 | UniProtKB/Swiss-Prot |
ZP_2 | UniProtKB/Swiss-Prot | |
SMART | SM00241 | UniProtKB/Swiss-Prot |
UniProt | B2R7J2 | ENTREZGENE |
Q05996 | ENTREZGENE | |
Q4VAN9 | ENTREZGENE | |
Q4VAP0 | ENTREZGENE | |
Q4VAP1 | ENTREZGENE | |
ZP2_HUMAN | UniProtKB/Swiss-Prot | |
UniProt Secondary | B2R7J2 | UniProtKB/Swiss-Prot |
Q4VAN9 | UniProtKB/Swiss-Prot | |
Q4VAP0 | UniProtKB/Swiss-Prot | |
Q4VAP1 | UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2016-04-04 | ZP2 | zona pellucida glycoprotein 2 | ZP2 | zona pellucida glycoprotein 2 (sperm receptor) | Symbol and/or name change | 5135510 | APPROVED |